Gastroenterology Market, By Drug Type, By Dosage Form, By Disease Type, By Distribution Channel, By Geography

Description

Global gastroenterology market is estimated to be valued at USD 35.12 Bn in 2024 and is expected to reach USD 53.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.1% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 35.12 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	6.10%	2031 Value Projection:	US$ 53.10 Bn

Figure. Gastroenterology Market Share (%), By Region, 2024

Global gastroenterology market growth is driven by rising gastrointestinal disorders such as stomach ulcer, inflammatory bowel disease, irritable bowel syndrome and growing geriatric population that requires effective diagnosis and treatment solutions. Furthermore, technological advancements in gastrointestinal endoscopy devices along with development of novel drugs for gastrointestinal issues can also drive the market growth. Various market players are engaged in new product launches and expansions to cater to increasing needs of healthcare facilities as well as patients. High costs associated with advanced gastroenterology devices and lack of awareness in low-income nations can pose challenges for broader patient access to care.

Market Dynamics:

Global gastroenterology market growth is driven by factors like growing prevalence of gastrointestinal disorders worldwide, increasing geriatric population susceptible to digestive diseases, and advancements in gastrointestinal medical devices. However, high costs associated with gastrointestinal instrumentation and endoscopy devices can hamper the market growth. Emergence of novel oral medicines for gastrointestinal issues and developing healthcare infrastructure in emerging nations can present lucrative opportunities for market expansion. North America dominates the global gasteroenterology market, owing to sizable patient population, fast approval of innovative therapies, and strategic initiatives by market players. However, Asia Pacific is expected to offer high growth prospects due to improving access to specialty care in nations like China and India.

(Key features of the study):

This report provides in-depth analysis of the global gastroenterology market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global gastroenterology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Medtronic, Johnson & Johnson, Abbott Laboratories, Hoffmann-La Roche, Bayer AG, GlaxoSmithKline, Sanofi, Pfizer, and Novartis AG

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global gastroenterology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gastroenterology market

Detailed Segmentation-

By Drug Type Insights (Revenue, USD Bn, 2019 - 2031)
- Biologics/Biosimilars
- Antacids
- Laxatives
- Antidiarrheal Agents
- Antiemetics
- Antiulcer Agents
- Others
By Dosage Form Insights (Revenue, USD Bn, 2019 - 2031)
- Oral
- Parenteral
- Others
By Disease Type Insights (Revenue, USD Bn, 2019 - 2031)
- Inflammatory Bowel Diseases (IBD)
- Crohn's Disease
- Ulcerative Colitis
- Irritable Bowel Syndrome (IBS)
- Gastroesophageal Reflux Disease (GERD)
- Liver Diseases
- Colorectal Cancer
- Others (Peptic Ulcers, etc.)
By Distribution Channel Insights (Revenue, USD Bn, 2019 - 2031)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Allied Digestive Health
- Boston Scientific
- Capital Digestive Care
- CRH Medical
- Iterative Scopes
- Fujifilm Medical
- Gastro Health
- GI Alliance
- Medtronic
- Micro-Tech Endoscopy
- Motus GI
- Olympus
- One GI
- PE GI Solutions
- Peak Gastroenterology Associates
- Pentax Medical
- Pinnacle GI Partners
- Saneso
- Surgical Innovations
- Wision A.I.

Product Code: CMI7416

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Dosage Form
- Market Snapshot, By Disease Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Gastroenterology Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Gastroenterology Market, By Drug Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Biologics/Biosimilars
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Antacids
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Laxatives
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Antidiarrheal Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Antiemetics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Antiulcer Agents
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Gastroenterology Market, By Dosage Form, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Parenteral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Gastroenterology Market, By Disease Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Inflammatory Bowel Diseases (IBD)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Crohn's Disease
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Ulcerative Colitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Irritable Bowel Syndrome (IBS)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Gastroesophageal Reflux Disease (GERD
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Liver Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Colorectal Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others (Peptic Ulcers, etc.)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Gastroenterology Market, By Distribution Channel, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Gastroenterology Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
Africa

10. Competitive Landscape

Company Profiles
- Allied Digestive Health
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Boston Scientific
- Capital Digestive Care
- CRH Medical
- Iterative Scopes
- Fujifilm Medical
- Gastro Health
- GI Alliance
- Medtronic
- Micro-Tech Endoscopy
- Motus GI
- Olympus
- One GI
- PE GI Solutions
- Peak Gastroenterology Associates
- Pentax Medical
- Pinnacle GI Partners
- Saneso
- Surgical Innovations
- Wision A.I.

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. Research Methodology

References
Research Methodology
About us and Sales Contact